Blue Biotechnology: Jointly developed new veterinary drug obtains new veterinary drug registration certificate.

Vland Biotech announced that the Qingying Granules jointly developed by the company is a Class 4 new veterinary drug in China and has obtained a new veterinary drug registration certificate, with a monitoring period of 3 years. Its function is to clear the nutrient phase and detoxify, and to dispel heat and nourish yin, and it is mainly indicated for the nutrient-phase syndrome caused by warm-heat pathogens in pigs. In addition, the triple inactivated vaccine against Streptococcus suis, Glaesserella parasuis, and porcine circovirus type 2 jointly developed by the company's wholly owned subsidiary Qingdao Vland Animal Health Group Co., Ltd. is a Class 3 new veterinary drug in China and has recently obtained a new veterinary drug registration certificate issued by the Ministry of Agriculture and Rural Affairs.